Search research articles
Contact Us
Filters
Showing results (531-540 of 589) with videos related to
Page
of 59
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial
B W Bode, J B Buse, M Fisher, et al.
Diabetes Care
|
June 8, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, et al.
Diabetes Technology & Therapeutics
|
July 11, 2018
Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange
Sarit Polsky, Mengdi Wu, Bruce W Bode, et al.
Nature
|
December 10, 1999
Crystal structures of the membrane-binding C2 domain of human coagulation factor V
S Macedo-Ribeiro, W Bode, R Huber, et al.
Science (New York, N.Y.)
|
May 24, 2021
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome
Pramod R Bhatt, Alain Scaiola, Gary Loughran, et al.
Diabetes Care
|
March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)
David Russell-Jones, Bruce W Bode, Christophe De Block, et al.
Diabetes Technology & Therapeutics
|
January 26, 2024
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod<sup>®</sup> 5 Automated Insulin Delivery System
Daniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, et al.
ACS Applied Materials & Interfaces
|
June 9, 2021
KAT Ligation for Rapid and Facile Covalent Attachment of Biomolecules to Surfaces
Alessandro Fracassi, Ankita Ray, Nako Nakatsuka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 16, 2002
The metabolism and excretion of galantamine in rats, dogs, and humans
G S J Mannens, C A W Snel, J Hendrickx, et al.
Mayo Clinic Proceedings
|
September 6, 2016
New Insulin Delivery Recommendations
Anders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Page
of 59
Search research articles
Search
Showing results (531-540 of 589) with videos related to
Sort By:
Page
of 59
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial
B W Bode, J B Buse, M Fisher, et al.
Diabetes Care
|
June 8, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, et al.
Diabetes Technology & Therapeutics
|
July 11, 2018
Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange
Sarit Polsky, Mengdi Wu, Bruce W Bode, et al.
Nature
|
December 10, 1999
Crystal structures of the membrane-binding C2 domain of human coagulation factor V
S Macedo-Ribeiro, W Bode, R Huber, et al.
Science (New York, N.Y.)
|
May 24, 2021
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome
Pramod R Bhatt, Alain Scaiola, Gary Loughran, et al.
Diabetes Care
|
March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)
David Russell-Jones, Bruce W Bode, Christophe De Block, et al.
Diabetes Technology & Therapeutics
|
January 26, 2024
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod<sup>®</sup> 5 Automated Insulin Delivery System
Daniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, et al.
ACS Applied Materials & Interfaces
|
June 9, 2021
KAT Ligation for Rapid and Facile Covalent Attachment of Biomolecules to Surfaces
Alessandro Fracassi, Ankita Ray, Nako Nakatsuka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 16, 2002
The metabolism and excretion of galantamine in rats, dogs, and humans
G S J Mannens, C A W Snel, J Hendrickx, et al.
Mayo Clinic Proceedings
|
September 6, 2016
New Insulin Delivery Recommendations
Anders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Page
of 59